Related Experiment Video
Updated: Aug 3, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
Interferon treatment for hepatitis B-associated membranous glomerulonephritis in two Chinese children
Insights
Interferon therapy offers a potential treatment for children with persistent nephrotic syndrome linked to chronic hepatitis B virus infection. While outcomes vary, it may induce remission or seroconversion in some cases.
Area of Science:
- Pediatric Nephrology
- Hepatology
- Virology
Background:
- Nephrotic syndrome in children can be associated with chronic hepatitis B virus (HBV) infection.
- Chronic carriers of hepatitis B surface antigen (HBsAg) and hepatitis B e antigen (HBeAg) may develop glomerulonephritis.
- Limited treatment options exist for persistent nephrotic syndrome secondary to HBV.
Observation:
- Two pediatric patients with persistent nephrotic syndrome and chronic HBV carriage (HBsAg+, HBeAg+) were studied.
- Renal biopsies revealed membranous glomerulonephritis, and liver biopsies showed chronic persistent hepatitis.
- Both patients received interferon-alpha-2a treatment after prolonged nephrotic syndrome.
Findings:
- Patient 1 achieved complete remission of nephrotic syndrome and hepatosplenomegaly, but remained positive for HBsAg, HBeAg, and HBV DNA.
- Patient 2 experienced a transient clinical response and seroconverted from HBeAg positive to anti-HBe positive.
- Treatment outcomes with interferon-alpha-2a were variable in these cases.
Implications:
- Interferon therapy is a consideration for severe, persistent nephrotic states associated with HBV.
- Further research is needed to optimize interferon treatment protocols for pediatric HBV-related glomerulonephritis.
- This study highlights the complex interplay between HBV infection and renal pathology in children.
Abstract:
Two Chinese boys, aged 3.5 and 5 years, developed nephrotic syndrome and were chronic carriers of hepatitis B virus surface antigen (HBsAg) and hepatitis B virus e antigen (HBeAg). Renal biopsy showed membranous glomerulonephritis and liver biopsy showed chronic persistent hepatitis. They were given interferon-alpha-2a at a dose of 5 MU/m2 on alternate days for 12 and 16 weeks after 2 years of persistent nephrotic syndrome. Patient 1 showed complete remission and resolution of hepatosplenomegaly, but his serum remained positive for HBsAg, HBeAg and hepatitis B virus DNA. Patient 2 showed only a transient clinical response and seroconversion from HBeAg to anti-HBe status. Although not always successful, interferon treatment should be considered in severe persistent nephrotic states, since there is at present no satisfactory treatment for this form of glomerulonephropathy.
More Related Videos
Related Concept Videos
Hepatitis
Inhibitors of Viral Protein Synthesis
Viral Hepatitis I: Introduction

